EMEA-000839-PIP01-10 - paediatric investigation plan

Aluminium hydroxide adsorbed, depigmented glutaraldehyde polymerised, allergen extract of Phleum pratense pollen

Key facts

• Active Substance:
  Aluminium hydroxide adsorbed, depigmented glutaraldehyde polymerised, allergen extract of Phleum pratense pollen
• Therapeutic area:
  Pneumology-allergology
• Decision number:
  P/255/2010
• PIP number:
  EMEA-000839-PIP01-10
• Pharmaceutical form(s):
  Suspension for injection
• Condition(s) / indication(s):
  • Treatment of allergic rhinitis
  • Treatment of rhino-conjuctivitis
• Route(s) of administration:
  Subcutaneous use
• Contact for public enquiries:

  LETI Pharma GmbH

  [e-mail]; Germany; Phone: [phone]; Fax: [phone]

• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  26/11/2010

Decision

P/255/2010: EMA decision of 26 November 2010 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for aluminium hydroxide adsorbed, depigmented glutaralde...

AdoptedReference Number: EMA/670695/2010